Metis Global Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
67,880
+30,959
| +84% | +$1.12M | 0.06% | 269 |
|
|
2025
Q1 | $1.15M | Buy |
36,921
+1,060
| +3% | +$33K | 0.03% | 434 |
|
|
2024
Q4 | $915K | Buy |
35,861
+14,124
| +65% | +$360K | 0.03% | 456 |
|
|
2024
Q3 | $615K | Buy |
21,737
+2,126
| +11% | +$60.1K | 0.02% | 531 |
|
|
2024
Q2 | $517K | Buy |
19,611
+6,065
| +45% | +$160K | 0.02% | 534 |
|
|
2024
Q1 | $411K | Buy |
13,546
+179
| +1% | +$5.44K | 0.01% | 596 |
|
|
2023
Q4 | $375K | Buy |
+13,367
| New | +$375K | 0.02% | 608 |
|